197
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Functional polymorphisms in the gene encoding macrophage migration inhibitory factor (MIF) are associated with active pulmonary tuberculosis

, , , , , , , & show all
Pages 222-228 | Received 20 Aug 2015, Accepted 30 Sep 2015, Published online: 06 Nov 2015

References

  • Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol. 2003;3:791–800.
  • Gregory JL, Morand EF, Mckeown SJ, et al. Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2. J Immunol. 2006;177:8072–8079.
  • Tillmann S, Bernhagen J, Noels H. Arrest Functions of the MIF Ligand/Receptor Axes in Atherogenesis. Front Immunol. 2013;16:115.
  • Santos LL, Morand EF. Macrophage migration inhibitory factor: a key cytokine in RA, SLE and atherosclerosis. Clin Chim Acta. 2013;399:1–7.
  • Morand EF, Leech M, Bemhagen J. MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nat Rev Drug Discov. 2006;5:399–410.
  • Baugh JA, Bucala R. Macrophage migration inhibitory factor. Crit Care Med. 2002;30:S27–S35.
  • Lolis E, Bucala R. Macrophage migration inhibitory factor. Expert Opinion on Therapeutic Targets. 2003;7:153–164.
  • Leng L, Bucala R. Macrophage migration inhibitory factor. Crit Care Med. 2005;33:S475–S477.
  • Calandra T, Bernhagen J, Metz CN, et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature. 1995;377:68–71.
  • Awandare GA, Martinson JJ, Were T, et al. MIF(macrophage migration inhibitory factor) promoter polymorphism and susceptibility to severe malarial anemia. J Infect Dis. 2009;200:629–637.
  • Yende S, Angus DC, Kong L, et al. The influence of macrophage migration inhibitory factor gene polymorphism on outcome from community-acquired pneumonia. FASEB J. 2009;23:2403–2411.
  • Renner P, Roger T, Bochud PY, et al. A functional microsatellite of the macrophage migration inhibitory factor gene associated with meningococal disease. FASEB J. 2012;26:907–916.
  • Hoi AY, Iskander MN, Morand EF. Macrophage migration inhibitory factor: a therapeutic target across inflammatory diseases. Inflamm Allergy Drug Targets. 2007;6:183–190.
  • Makino A, Nakamura T, Hirano M, et al. High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus. Atherosclerosis. 2010;213:573–578.
  • Ma L, Xue HB, Guan XH, et al. Relationship of macrophage migration inhibitory factor levels in PBMCs, lesional skin and serum with disease severity and anctvity in vitiligo vulgaris. Braz J Med Biol Res. 2013;46:460–464.
  • Radstake TR, Sweep FC, Welsing P, et al. Correlation of rheumatold arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum. 2005;52:3020–3029.
  • Das R, Koo MS, Kim BH, et al. Macrophage migration inhibitory factor(MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis. Proc Natl Acad Sci USA. 2013;110:E2997–3006.
  • Li YL, Yuan T, Lu WP, et al. Association of tuberculosis and polymorphisms in the promoter region of macrophage migration inhibitory factor(MIF) in a Southwestern China Han population. Cytoine. 2012;60:64–67.
  • Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215–1215.
  • Makhija R, Kingsnorth A, Demaine A. Gene polymorphisms of the macrophage migration inhibitory factor and acute pancreatitis. JOP. 2007;8:289–295.
  • Sreih A, Ezzeddine R, Leng L, et al. Dual effect of the Macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus. Arthritis Rheum. 2011;63:3942–3951.
  • Yim JJ, Selvaraj P. Genetic susceptibility in tuberculosis. Respirology. 2010;15:241–256.
  • Vasilca V, Oana R, Munteanu D, et al. HLA-A and HLA-B phenotype associated with tuberculosis in population from north-eastern Romania. Roum Arch Microbiol Immunol. 2004;63:209–221.
  • Malik S, Abel L, Tooker H, et al. Alleles of the NRAMP1 gene are risk factors for pediatric tuberculosis disease. Proc Natl Acad Sci USA. 2005;102:12183–12188.
  • Dissanayeke SR, Levin S, Pienaar S, et al. Polymorphic variation in TLRAP is not associated with susceptibility to childhood TB but may determine susceptibility to TBM in some ethnic groups. PLoS One. 2009;4:e6698.
  • Liu W, Cao WC, Zhang CY, et al. VDR and NRAMP1 gene polymorphism in susceptibility to pulmonary tuberculosis among the Chinese Han population: a case-control study. Int J Tuberc Lung Dis. 2004;8:428–434.
  • EI Sahly-HM, Reich RA, Dou SJ, et al. The effect of mannose binding lectin gene polymorphism on susceptibility to tuberculosis in different ethnic groups. Scand J Infect Dis. 2004;36:106–108.
  • Tosh K, Campbell SJ, Fielding K, et al. Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West Africa. Proc Natl Acad Sci USA. 2006;103:10364–10368.
  • Velez DR, Hulme WF, Myers JL, et al. NOS2A, TLR4, and IFNGR1 interactions influence pulmonary tuberculosis susceptibility in African-Americans. Hum Genet. 2009;126:643–653.
  • Donn R, Alourfi Z, De Benedetti F, et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum. 2002;46:2402–2409.
  • Temple SE, Cheong KY, Price P, Waterer GW. The microsatellite, macrophage migration inhibitory factor −794, may influence gene expression in human mononuclear cells stimulated with E. coli or S. pneumoniae. Int J Immunogenet. 2008;35:309–316.
  • Llamas-Covarrubias MA, Valle Y, Bucala R, et al. Macrophage migration inhibitory factor(MIF): genetic evidence for participation in early onset and early stage rheumatoid arthritis. Cytokine. 2013;61:759–765.
  • Chen YC, Zhang XW, Niu XH, et al. Macrophage migration inhibitory factor is a direct target of HBP1-midiated transcriptional repression that is overexpressed in prostate cancer. Oncogene. 2010;29:3067–3078.
  • Calandra T, Bernhagen J, Mitchell RA, Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med. 1994;124:471–474.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.